Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking

Abstract Background Polycystic ovary syndrome (PCOS) is an endocrine disease associated with reproductive and metabolic abnormalities. The aim of this study was to elucidate the effects of Schisandra rubriflora (S. rubriflora) on PCOS and its related mechanisms using network pharmacology, molecular...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengyan Dou, Qingxian Li, Jing Zhang, Xin Zhang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-025-01600-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571478064758784
author Zhengyan Dou
Qingxian Li
Jing Zhang
Xin Zhang
author_facet Zhengyan Dou
Qingxian Li
Jing Zhang
Xin Zhang
author_sort Zhengyan Dou
collection DOAJ
description Abstract Background Polycystic ovary syndrome (PCOS) is an endocrine disease associated with reproductive and metabolic abnormalities. The aim of this study was to elucidate the effects of Schisandra rubriflora (S. rubriflora) on PCOS and its related mechanisms using network pharmacology, molecular docking and in vitro experiments. Materials and methods HERB database and SwissTargetPrediction database were used to obtain the active components and the targets of S. rubriflora. Differentially expressed genes (DEGs) associated with PCOS were obtained by analyzing GSE54248 dataset. A protein-protein interaction network was constructed, and topological analyses were performed to identify the hub targets and main bioactive components. The binding abilities between hub targets and key components were studied by molecular docking. Finally, in vitro PCOS models were constructed with KGN cells and rat ovarian granulosa cells, respectively, and the regulatory effects of schisandrin, a key bioactive component of S. rubriflora, on the cells were investigated by in vitro assays. Results A total of 14 bioactive ingredients of S. rubriflora and 26 potential therapeutic targets of S. rubriflora in PCOS treatment were obtained. Bioinformatics analyses suggested that the mechanisms of S. rubriflora in treating PCOS were related to IL-17 signaling pathway and TNF signaling pathway. The binding affinities between key components of S. rubriflora (schisandrin, wyerone, and rugosal) and hub targets (PTGS2, MMP9, MCL1, and JUN) were high. Schisandrin could attenuate lipopolysaccharide-induced inflammation, oxidative stress, and apoptosis of KGN cells and rat ovarian granulosa cells, as well as inhibit hub target expression and TNF pathway activation. Conclusion PTGS2, MMP9, MCL1 and JUN are potential targets for S. rubriflora to treat PCOS. Schisandrin, a main component of S. rubriflora, may be a candidate for the treatment of PCOS. Graphical Abstract
format Article
id doaj-art-ceafd61933124b359530d7fe7bc3b356
institution Kabale University
issn 1757-2215
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj-art-ceafd61933124b359530d7fe7bc3b3562025-02-02T12:37:01ZengBMCJournal of Ovarian Research1757-22152025-01-0118112010.1186/s13048-025-01600-xExploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular dockingZhengyan Dou0Qingxian Li1Jing Zhang2Xin Zhang3Department of Operation Room, Second Affiliated Hospital of Naval Medical UniversityDepartment of Reproductive Medicine Center, Second Affiliated Hospital of Naval Medical UniversityDepartment of Integrative Therapy, Fudan University Cancer HospitalDepartment of Reproductive Medicine Center, Second Affiliated Hospital of Naval Medical UniversityAbstract Background Polycystic ovary syndrome (PCOS) is an endocrine disease associated with reproductive and metabolic abnormalities. The aim of this study was to elucidate the effects of Schisandra rubriflora (S. rubriflora) on PCOS and its related mechanisms using network pharmacology, molecular docking and in vitro experiments. Materials and methods HERB database and SwissTargetPrediction database were used to obtain the active components and the targets of S. rubriflora. Differentially expressed genes (DEGs) associated with PCOS were obtained by analyzing GSE54248 dataset. A protein-protein interaction network was constructed, and topological analyses were performed to identify the hub targets and main bioactive components. The binding abilities between hub targets and key components were studied by molecular docking. Finally, in vitro PCOS models were constructed with KGN cells and rat ovarian granulosa cells, respectively, and the regulatory effects of schisandrin, a key bioactive component of S. rubriflora, on the cells were investigated by in vitro assays. Results A total of 14 bioactive ingredients of S. rubriflora and 26 potential therapeutic targets of S. rubriflora in PCOS treatment were obtained. Bioinformatics analyses suggested that the mechanisms of S. rubriflora in treating PCOS were related to IL-17 signaling pathway and TNF signaling pathway. The binding affinities between key components of S. rubriflora (schisandrin, wyerone, and rugosal) and hub targets (PTGS2, MMP9, MCL1, and JUN) were high. Schisandrin could attenuate lipopolysaccharide-induced inflammation, oxidative stress, and apoptosis of KGN cells and rat ovarian granulosa cells, as well as inhibit hub target expression and TNF pathway activation. Conclusion PTGS2, MMP9, MCL1 and JUN are potential targets for S. rubriflora to treat PCOS. Schisandrin, a main component of S. rubriflora, may be a candidate for the treatment of PCOS. Graphical Abstracthttps://doi.org/10.1186/s13048-025-01600-xPolycystic ovary syndromeS. RubrifloraNetwork pharmacologySchisandrinOvarian granulosa cells
spellingShingle Zhengyan Dou
Qingxian Li
Jing Zhang
Xin Zhang
Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
Journal of Ovarian Research
Polycystic ovary syndrome
S. Rubriflora
Network pharmacology
Schisandrin
Ovarian granulosa cells
title Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
title_full Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
title_fullStr Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
title_full_unstemmed Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
title_short Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
title_sort exploring the mechanism of schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
topic Polycystic ovary syndrome
S. Rubriflora
Network pharmacology
Schisandrin
Ovarian granulosa cells
url https://doi.org/10.1186/s13048-025-01600-x
work_keys_str_mv AT zhengyandou exploringthemechanismofschisandrarubriflorainthetreatmentofpolycysticovarysyndromebasedonnetworkpharmacologyandmoleculardocking
AT qingxianli exploringthemechanismofschisandrarubriflorainthetreatmentofpolycysticovarysyndromebasedonnetworkpharmacologyandmoleculardocking
AT jingzhang exploringthemechanismofschisandrarubriflorainthetreatmentofpolycysticovarysyndromebasedonnetworkpharmacologyandmoleculardocking
AT xinzhang exploringthemechanismofschisandrarubriflorainthetreatmentofpolycysticovarysyndromebasedonnetworkpharmacologyandmoleculardocking